article thumbnail

FDA Solicits Feedback on the Use of AI and Machine Learning in Drug Development

Bill of Health

Food and Drug Administration (FDA), in fulfilling its task of ensuring that drugs are safe and effective, has recently turned its attention to the growing use of artificial intelligence (AI) and machine learning (ML) in drug development. By Matthew Chun The U.S. manufacturing process design), implement advanced process controls (e.g.,

FDA 261
article thumbnail

Unpacking Averages: Exploring New Data on FDA Responses to FOIA Requests

Health Law Advisor

To provide more value to readers, I’ve started submitting FOIA requests for unpublished data to produce additional insights into how FDA works. And what better first topic than data on FDA responses to FOIA requests. FDA has been releasing data on its FOIA process, specifically its FOIA logs , for a few years. We were wrong.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Expands Access to Mifepristone: Next Steps for Providers and Retail Pharmacies

Hall Render

Food and Drug Administration (“FDA”) released an updated Mifepristone Risk Evaluation and Mitigation Strategy (the “Mifepristone REMS Program”), which reverses the requirement that the drug be dispensed directly to a patient by certified prescriber in a clinic or a medical office (the “in-person dispensing requirement”).

FDA 40
article thumbnail

Petrie-Flom Welcomes 2022-2023 Student Fellows

Bill of Health

They each will undertake a year-long research project with mentorship from Center faculty and affiliates, and also will blog here at Bill of Health regularly. She has previously published articles on synthetic biology regulation and governance, end stage renal disease payment reform, and comparative analyses of learning disorder policy.

Bioethics 130
article thumbnail

Streamlining Compliance in the Pharmaceutical Industry with the eQMS

Dot Compliance

In this blog post, we’ll explore how quality management is essential for meeting regulatory standards and maintaining the efficacy, safety and high quality of pharmaceutical products. Governing bodies such as the U.S. The FDA ensures that drug manufacturing processes align with these CGMP objectives.

article thumbnail

Incorporation by Reference Does Not Create a Material Condition of Payment

Hall Render

Defendant pharmaceutical manufacturers applied for and received approval from the FDA to manufacture Gamunex at a facility converted for that purpose. FDA regulations require current Good Manufacturing Practices [cGMP] to be met or the drug shall be deemed adulterated and prohibited from sale. United States ex rel. at *1 & fn.

FDA 40
article thumbnail

U.S. Food and Drug Administration Issues Draft Guidance Updating Good Clinical Practices 

Hall Render

Food and Drug Administration (“FDA”) released draft guidance (“Draft Guidance”) updating Good Clinical Practices (“GCPs”) recommendations for interventional clinical trials involving human subjects. Data Governance The Draft Guidance also strengthens the existing focus on data governance from both a sponsor and investigator perspective.

FDA 40